Coagulation Counseling

Anna D. Garrett, PharmD, BCPS, CPP
Published Online: Monday, March 15, 2010
Dr. Garrett is manager of the Health Education Center at Mission Hospitals in Asheville, North Carolina.

March is DVT Awareness Month
Seven years ago, NBC correspondent David Bloom died from a pulmonary embolus (PE) he suffered while covering the war in Iraq. He was embedded with a military unit and riding in a tank for long periods of time when the event occurred. Since then, his wife, Melanie, has campaigned to raise awareness of the dangers of deep vein thrombosis (DVT). Her work culminated with the declaration of March as DVT Awareness Month.

According to the American Heart Association, up to 2 million Americans are affected annually by DVT. Of those who develop a PE, up to 200,000 will die each year. More Americans die annually from DVT/PE than from breast cancer and AIDS combined. Despite these statistics, a national survey sponsored by the American Public Health Association showed that 74% of Americans have little or no awareness of DVT. Even more disturbing is the fact that 58% of patients who developed a DVT while in the hospital received no preventive treatment, despite the presence of multiple risk factors and overwhelming data that prophylaxis is very effective at reducing these events.

An extensive listing of DVT Awareness Month tools and activities is posted at Get involved! You may help save a life.

Latest Articles
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about some safeguards pharmacists can implement.
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Latest Issues